MC
ZURA icon

Meteora Capital’s Zura Bio ZURA Stock Holding History

Meteora Capital’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,702
Closed -$73.8K – 265
2024
Q1 		$73.8K Hold
28,702
– – 0.01% 173
2023
Q4 		$2.16K Buy
+28,702
New +$143K ﹤0.01% 265
2022
Q3 		– Sell
-18,206
Closed -$181K – 417
2022
Q2 		$181K Buy
+18,206
New +$181K 0.03% 258

Other funds holding ZURA

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meteora Capital's ZURA Position: Q2 2024 in Review

Meteora Capital sold out of Zura Bio (ZURA) in Q2 2024, closing a stake of 28,702 shares — an estimated $73.8K sold.

Meteora Capital first reported a position in ZURA in Q2 2022 and held it in 3 quarters. The position peaked at $181K in Q2 2022. 57 funds tracked by Wall St. Rank hold ZURA as of Q2 2024.

  • Meteora Capital reported no remaining Zura Bio position as of Q2 2024 after selling out during the quarter.
  • Meteora Capital sold 28,702 Zura Bio shares in Q2 2024, an estimated $73.8K.
  • Meteora Capital first reported a position in Zura Bio in Q2 2022 and held it in 3 quarters.
  • Meteora Capital's Zura Bio position peaked at $181K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Zura Bio as of Q2 2024.

Based on Meteora Capital's 13F filing for Q2 2024, filed 14 Aug 2024.